---
figid: PMC3323126__embor201211f3
figtitle: 'Merlin: a tumour suppressor with functions at the cell cortex and in the
  nucleus'
organisms:
- NA
pmcid: PMC3323126
filename: embor201211f3.jpg
figlink: /pmc/articles/PMC3323126/figure/f3/
number: F3
caption: The convergence of several upstream adhesion receptors regulates Merlin (Mer)
  activation and subsequently controls downstream mitogenic pathways. (A) The assembly
  of cell-to-cell adhesions and CD44 activation by hyaluronic-acid-rich matrix activates
  MYPT1, which dephosphorylates Merlin Ser 518 and maintains it in a closed and active
  conformation. Conversely, in sparse cells exposed to growth factors, integrins and
  receptor tyrosine kinases activate PAK, phosphorylating Ser 518. PKA—activated by
  increased cAMP—also phosphorylates Ser 518. (B) Merlin can affect a variety of mitogenic
  signalling pathways, including Rac–PAK signalling, mTORC1, EGFR–Ras–ERK and the
  PI3K–Akt pathway. In addition, Merlin contributes to the activation of the Hippo
  tumour-suppressor pathway. The active form of Merlin can enter the nucleus, bind
  to and inactivate the E3 ubiquitin ligase CRL4DCAF1. Akt, protein kinase B; cAMP,
  cyclic AMP; CRL4, cullin-ring E3 ligase 4; DCAF1, DDB1- and CUL4-associated factor
  1; EGFR, epidermal growth factor receptor; ERK, extracellular-signal-regulated kinase;
  mTORC1, mammalian target of Rapamycin complex 1; MYPT1, myosin phosphatase targeting
  subunit 1; PAK, p21-activated kinase; PI3K, phosphatidylinositol 3-kinase; PKA,
  protein kinase A; Rac, Ras-related C3 botulinum toxin substrate; Ras, rat sarcoma.
papertitle: 'Merlin: a tumour suppressor with functions at the cell cortex and in
  the nucleus.'
reftext: Wei Li, et al. EMBO Rep. 2012 Mar;13(3):204-215.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9397433
figid_alias: PMC3323126__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3323126__F3
ndex: a3ad7b71-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3323126__embor201211f3.html
  '@type': Dataset
  description: The convergence of several upstream adhesion receptors regulates Merlin
    (Mer) activation and subsequently controls downstream mitogenic pathways. (A)
    The assembly of cell-to-cell adhesions and CD44 activation by hyaluronic-acid-rich
    matrix activates MYPT1, which dephosphorylates Merlin Ser 518 and maintains it
    in a closed and active conformation. Conversely, in sparse cells exposed to growth
    factors, integrins and receptor tyrosine kinases activate PAK, phosphorylating
    Ser 518. PKA—activated by increased cAMP—also phosphorylates Ser 518. (B) Merlin
    can affect a variety of mitogenic signalling pathways, including Rac–PAK signalling,
    mTORC1, EGFR–Ras–ERK and the PI3K–Akt pathway. In addition, Merlin contributes
    to the activation of the Hippo tumour-suppressor pathway. The active form of Merlin
    can enter the nucleus, bind to and inactivate the E3 ubiquitin ligase CRL4DCAF1.
    Akt, protein kinase B; cAMP, cyclic AMP; CRL4, cullin-ring E3 ligase 4; DCAF1,
    DDB1- and CUL4-associated factor 1; EGFR, epidermal growth factor receptor; ERK,
    extracellular-signal-regulated kinase; mTORC1, mammalian target of Rapamycin complex
    1; MYPT1, myosin phosphatase targeting subunit 1; PAK, p21-activated kinase; PI3K,
    phosphatidylinositol 3-kinase; PKA, protein kinase A; Rac, Ras-related C3 botulinum
    toxin substrate; Ras, rat sarcoma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - Egfr
  - Mer
  - kibra
  - Pak
  - mbt
  - mst
  - hpo
  - Mst84Dd
  - Mst84Dc
  - Mst84Db
  - Mst84Da
  - CG12279
  - Mst87F
  - Mst98Cb
  - Mst98Ca
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Sos
  - sav
  - Mob2
  - ras
  - Ras64B
  - wts
  - Crtc
  - 14-3-3zeta
  - 14-3-3epsilon
  - pk
  - Erk7
  - rl
  - Oamb
  - yki
  - Taz
  - Dis3
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - sd
  - scb
  - CD44
  - EGFR
  - GPER1
  - MERTK
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - WWC1
  - PPP1R12A
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - STK3
  - MST1
  - STK4
  - MAP3K10
  - MPST
  - TAM
  - MSTO1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - XYLT2
  - SOS1
  - SOS2
  - SAV1
  - KRAS
  - HRAS
  - NRAS
  - LATS2
  - LATS1
  - MTOR
  - RPTOR
  - YWHAQ
  - EPHB2
  - MAPK1
  - MAPK3
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - TAFAZZIN
  - WWTR1
  - YAP1
  - AKT2
  - AKT3
  - PTPA
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - tyrosine
  - Cancer
---
